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Predictors of problematic substance use 18 years
after treatment: a longitudinal cohort study of
persons with substance use disorders
Arne Jan Hjemsæter1,2*, Jørgen Gustav Bramness1,3, Robert Drake4, Ivar Skeie2,5,
Bent Monsbakken1,2, Magne Thoresen6 and Anne Signe Landheim1,7
Abstract: Objective: To examine the extent of substance use and explore which
baseline factors predicted current problematic substance use 18 years after treatment
in surviving patients.Methods: This longitudinal cohort study used a mailed self-report
questionnaire on a group of patients with long-term problematic substance use, and
high psychiatric comorbidity, 18 years after they received treatment for substance use
disorders. A consecutive sample of patients with substance use disorders (n = 287,
mean age 38.6 years, 72% male; 45% alcohol use disorder only and 55% other
substance use disorders) was recruited in 1997 and 1998. Baseline measurements
included the Composite International Diagnostic Interview, the Millon Clinical
Multiaxial Inventory II, the Hopkins Symptom Checklist 25 and demographic data. In
the 18-year follow-up study (n = 91), the Alcohol Use Disorders Identification Test and
the Drug Use Disorders Identification Test were used. A multivariate logistic regression
analysis was used to identify predictors of having current problematic substance use
18 years after treatment for participants with full data collection at baseline (n = 75).
Results: Of the 91 participantswho responded at the 18-year follow-up study, 47 (52%)
had no current problematic substance use and 44 (48%) had current problematic
substance use during the past 12 months. Of participants with no current problematic
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substance use, 17 (36%) reported total abstinence from alcohol, illicit substances and
misuse of pharmaceuticals during the past 5 years. Mental distress measured with the
Hopkins Symptom Checklist 25 at baseline predicted having current problematic sub-
stance use 18 years after treatment (n = 75). Conclusions: In a group of patients with
long lasting substance use disorders and high psychiatric comorbidity that entered
treatment, close to half of those participating at a follow-up study had current pro-
blematic substance use during the past 12 months 18 years later. Mental distress at
baseline predicted having current problematic substance use 18 years after treatment,
adjusted for other factors. Self-reported general mental health symptoms can be
a relevant predictor of the long-term course of substance use disorders.
Subjects: Mental Health; Psychiatry & Clinical Psychology - Adult; Mental Health Research;
Psychological Disorders - Adult; Addiction - Alcohol - Adult; Mood Disorders in Adults -
Depression, Mania,Bi-polar; Addiction - Drugs - Adult; Addiction Disorders - Adult; Anxiety
in Adults; Psychiatry
Keywords: substance use disorder; predictors substance use relapse; mental distress;
psychiatric disorders; comorbidity; longitudinal
1. Introduction
Remission and relapse rates over time vary between substances and subgroups of persons with
substance use disorders (SUDs), and persons can fluctuate between periods of problematic use,
nonproblematic use and abstinence (Heyman, 2013). The literature on predictors of outcome of
SUDs is inconsistent, but emphasized general factors are: age of SUD onset (Landheim, Bakken, &
Vaglum, 2006), SUD severity and type or number of substances used, psychiatric comorbidity,
psychological factors such as negative affective states, coping skills and motivation, length of
treatment, sleep, and genetic and socioeconomic factors (Ciraulo, Piechniczek-Buczek, & Iscan,
2003). There are few longitudinal studies on outcome predictors in patients with polysubstance
use (Andreas, Lauritzen, & Nordfjaern, 2015), but we have previously shown in a clinical cohort of
patients with different SUDs that lifetime major depressive disorder is a predictor of having
problematic substance use 6 years after entering SUD-treatment (Landheim et al., 2006).
Examples of outcome predictors on specific SUDs show that for patients with alcohol use disorder
(AUD) low self-efficacy and avoidant coping-strategies are predictors of alcohol use relapse
16 years later (Moos & Moos, 2006), while, surprisingly, childhood psychological vulnerabilities do
not predict long-term alcohol use relapse (Valliant, 1995). For opioid dependence high self-efficacy
and low psychological distress predict stable recovery 10 years later (Hser, 2007), while exposure
to physical or sexual abuse and comorbid mental disorders predict continued opioid use (Hser,
Evans, Grella, Ling, & Anglin, 2015).
Different aspects of mental health, including mental disorders, appear relevant for understand-
ing substance use relapse and the long-term course of SUDs. High comorbidity between SUDs and
mental disorders is well documented (Lai, Cleary, Sitharthan, & Hunt, 2015; Landheim, Bakken, &
Vaglum, 2002; Regier et al., 1990). This comorbidity reduces quality of life (Colpaert, De Maeyer,
Broekaert, & Vanderplasschen, 2012) and leads to lower treatment adherence (Weiss, Smith, Hull,
Piper, & Huppert, 2002) and poorer treatment outcome (Bahorik, Newhill, & Eack, 2013), including
increased SUD severity and more frequent relapses and hospitalizations (Morisano, Babor, &
Robaina, 2014). The relationships, including the causal direction, between different types and
levels of SUDs and various mental health problems continue to be debated (Kessler, 2004;
Swendsen et al., 2010). Research on clinical cohorts with severe SUDs is demanding and complex,
and there is a paucity of longitudinal studies, especially of polysubstance use and predictors of
outcomes and the severity of long-term SUDs. Progress in understanding the long-term course of
SUDs will require prospective studies with long observational times on heterogeneous clinical
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cohorts. Improved understanding is important for the development of tailored effective prevention
and treatment programs for a diverse group of patients.
The current study examined a heterogeneous cohort of patients with long lasting problematic
use of various substances when entering specialized treatments for substance abuse 18 years ago.
The cohort had high comorbidity with lifetime mental disorders assessed at baseline. The aims
were to examine the extent of substance use, and explore which baseline factors predicted the
presence of problematic substance use18 years after treatment in surviving participants.
2. Methods
2.1. Design
This was a longitudinal cohort study with an observation period of 18 years. Patients entering
specialized treatment for SUDs in public facilities in two Norwegian counties in 1997 and 1998
were invited to participate in the study (baseline). A follow-up study was conducted by questionnaire
to living participants approximately 18 years later (the 18-year follow-up study). The study protocol
was reviewed and approved at baseline and the 18-year follow-up by the Regional Committee for
Medical and Health Research Ethics, Health Region South-East (ID 2014/1936 C). All participants
gave their written consent before taking part in the study, and to be contacted for follow-up studies.
2.2. Sample
At baseline, 287 patients with SUDs (mean age 38.6 years ± standard deviation [SD] 11.3 years,
72% male) were recruited. Among these patients 130 (45%) had only AUD and 157 (55%) other
SUDs, 166 (58%) came from six inpatient units and 121 (42%) from three outpatient units. At
baseline, the prevalence of lifetime mental disorders (other than SUDs and personality disorders) in
the sample was 91%; 83% had lifetime anxiety disorder, 65% had lifetime affective disorder, and
63% had three or more lifetime mental disorders (Landheim et al., 2002). The most prevalent
lifetime mental disorders at baseline (other than SUD and personality disorders) was agoraphobia
with or without panic (48%), social phobia (47%), specific phobia (46%) and major depressive
disorder (44%). The mean duration since first onset SUD at baseline was 13.8 years (SD 8.8 years)
and 46% had SUD onset before the age of 18 years. Among the patients with other SUDs than only
AUD; 53% had lifetime opioid dependence, 50% stimulant dependence, 50% sedative, hypnotic or
anxiolytic dependence, 42% cannabis dependence and 66% also had lifetime alcohol dependence.
Among the patients with other SUDs than only AUD, the mean number of lifetime SUDs was 3.6
(SD = 2.0). Sampling, subjects and methods at baseline have been previously described more
extensively (Landheim, Bakken, & Vaglum, 2003; Landheim et al., 2006). Compared with
a national sample (n = 5000) of patients in facilities for specialized treatment for SUD in Norway
in the same period, our sample was skewed toward having older patients with a longer duration of
SUD and a higher frequency of AUD (Landheim et al., 2003).
The 18-year follow-up study was conducted between October 2015 and March 2016 by a mailed by
post questionnaire to living participants, approximately 18 years after entering treatment. The ques-
tionnaire included a return-envelope with postage paid, a general description of the study, a form to
decline participation, and an offer that participants who answered and returned the questionnaire
within approximately 3 weeks, would receive 400 Norwegian kroner (~ 43 euros in 2016) to their
reported bank account. Participants were informed that estimated time to fill out the questionnaire
was between 30 and 60 minutes. There was no means to monitor when, how or where participants
answered the questionnaire. The questionnaire was sent out a second time to participants who did not
respond the first time. Those still not responding were contacted once by telephone to confirm that
they had received the questionnaire. In the 18-year follow-up study, 91 (32%) subjects participated
(mean age 54.9 ± 10.0 years, 70% male), 93 (32%) subjects were deceased (mean age
53.5 ± 11.7 years at time of death, 80% male) and 103 (36%) did not participate (mean age
53.2 ± 10.9 years, 67% male (21 declined, 10 were not located and 72 did not respond)).
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2.3. Measurements
Baseline: For all measurements in the study, the Norwegian versions used in clinical practice and
research were used. The Composite International Diagnostic Interview (CIDI), Norwegian computer
version, a structured personal psychiatric interview based on DSM-IV criteria and the correspond-
ing lifetime nonhierarchical diagnoses in the ICD-10 (Robins et al., 1988) were used. The reliability
of the CIDI has been demonstrated to be excellent, and the validity to be adequate (Andrews &
Peters, 1998). The Millon Clinical Multiaxial Inventory II (MCMI-II), a self-report psychiatric diag-
nostic (DSM-III-R) inventory (Choca, Shanley, & Van Denburg, 1992) was used to measure current
personality disorders. The manual states that the MCMI-II has acceptable test-retest reliability,
good internal consistency, and generally acceptable levels of validity (Millon, 1987), but there has
also been raised concerns about insufficient stability (Zimmerman, 1994), and overdiagnosis
among persons with SUDs (Flynn, McCann, & Fairbank, 1995) for the personality disorders.
Personality disorder diagnoses were given using a cutoff base-rate score of 85 or higher. The
Hopkins Symptom Checklist-25 (HSCL-25), a self-report instrument consisting of 25 items on
a four-point scale, mainly anxiety and depression symptoms, was used to measure mental distress
during the last week (Derogatis, Lipman, Rickels, Uhlenhuth, & Covi, 1974). The HSCL-25 has proved
satisfactory validity and reliability as a measure of mental distress (Strand, Dalgard, Tambs, &
Rognerud, 2003). The Norwegian National Client Assessment form (Gerdts & Iversen, 2000) which
covers information on sociodemographics and treatment history was also used.
The 18-year follow-up: the Alcohol Use Disorders Identification Test (AUDIT) (Saunders, Aasland,
Babor, De la Fuente, & Grant, 1993) and the Drug Use Disorders Identification Test (DUDIT)
(Berman, Bergman, Palmstierna, & Schlyter, 2004), both self-report screening instruments for
identifying problematic use of substances during the past 12 months were also used. The AUDIT
consists of 10 items and a cutoff score of 8 or more for men and 6 or more for women was used.
A review concluded that the AUDIT is psychometrically sound and that research on validity
consistently confirms sensitivities and specificities comparable to and generally exceeding those
of other alcohol use screening methods (Reinert & Allen, 2007). The DUDIT has 11 items and
a cutoff score of 6 or more for men and 2 or more for women was used. A review concluded that
the DUDIT yields satisfactory measures of reliability and validity for use as a clinical or research
tool (Hildebrand, 2015). Questions on use of alcohol, illicit substances, and misuse of pharmaceu-
ticals during the last 5 years were also included in the questionnaire. Participants in the 18-year
follow-up study were divided into those with “no current problematic substance use” (AUDIT <
cutoff and DUDIT < cutoff during the past 12 months at the 18-year follow-up) and participants
with “current problematic substance use” (AUDIT ≥ cutoff and/or DUDIT ≥ cutoff during the past
12 months at the 18-year follow-up).
The HSCL-25 was not answered at baseline by 13 of the participants in the 18-year follow-up
study, and the MCMI-II was not answered at baseline by 8 of the participants in the 18-year follow-
up study. There were no missing items on AUDIT, DUDIT or other relevant measurements in the 18-
year follow-up study.
Figure 1 shows a flow diagram illustrating participation and loss of participants during the study,
and the foundation for analyzed data.
Table 1 provides characteristics as age, gender and selected factors regarding substance use
and mental health measured at baseline for participants (n = 91), nonparticipants (n = 103)
and deceased (n = 93) in the 18-year follow-up study. A comparison with bivariate simple
statistical tests between participants and nonparticipants showed no significant differences
(Table 1). We also compared the participants in the 18-year follow-up study with complete
data collection at baseline (n = 75) with nonparticipants (n = 103) and still did not find
significant differences between the groups. A comparison between the participants (n = 91)
and the deceased (n = 93) in the 18-year follow-up study, displayed in Table 1, showed that the
deceased were older, more seldom had onset first SUD before age 18 years, shorter duration
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since first onset SUD, more often had only AUD, more seldom had lifetime affective disorder
and more often received inpatient treatment at baseline (all p < 0.05).
2.4. Statistical analysis
Participants were compared with nonparticipants and deceased, and participants with no current
problematic substance use were compared with participants with current problematic substance use
at the time of the 18-year follow-up study using demographic variables, mental disorders, mental
distress and substance use variables measured at baseline with simple statistical tests: χ2-test for
categorical variables, and t-tests and Mann–Whitney U tests for continuous variables. Because of
restricted sample size in the 18-year follow-up study, separate mental disorders at baseline were
clustered into lifetime affective disorders, lifetime anxiety disorders, and current personality disorders.
A logistic regression model giving odds ratios (OR) and 95% confidence intervals (95% CI) of
having current problematic substance use at the time of the 18-year follow-up study was con-
structed for participants with complete data collection at baseline and at the 18-year follow-up
study (n = 75). All covariates with p < 0.2 (Hosmer & Lemeshow, 2000) from the unadjusted analysis,
plus age and gender, were included in a multivariate analysis. All correlations between covariates
were < 0.7. In the multivariate model, p < 0.05 was considered significant and defined “predictor”.
All analyses were conducted using IBM SPSS Statistics for Windows (version 23.0; IBM Corp.,
Armonk, NY).
3. Results
In the 18 year follow-up, 47 (52%) participants had no current problematic substance use and 44
(48%) had current problematic substance use during the past 12 months. Among the participants
with no current problematic substance use at the 18-year follow-up, 26 (55%) reported no use of
alcohol or illicit substances, while 21 (45%) used alcohol or illicit substances, or both, under the
cutoff values during the past 12 months. During the 5 years immediately preceding the 18-year
follow-up study, 17 (36%) of the participants with no current problematic substance use reported
18-year follow-up (2015/2016):
n = 91
Deceased: n = 93
Non-participants: n = 103
(Declined: n = 21, Not located: n = 
1 , Not returning questionnaire: 0 n
= 72)
Participants and Data Collection 
Complete data at the 18-year follow-up: 
n = 75
Missing data HSCL-25 and /or 
MCMI-II at baseline: n = 16
Baseline (1997/1998):
n = 287
Figure 1. Flow diagram; partici-
pants, data collection and ana-
lyzed data during the study.
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total abstinence from any substance use (alcohol, illicit substances, and misuse of pharmaceuti-
cals). For the participants with current problematic substance use at the 18-year follow-up, the
mean score on the AUDIT was 13.8 (SD = 11.4) and that on the DUDIT was 12.1 (SD = 11.8).
Table 2 shows a comparison for participants with complete data collection (n = 75) between those
with no current problematic substance use (52%) and those with current problematic substance use
(48%) at the time of the 18-year follow-up using selected demographic, mental health, and substance
use variables. We found no differences between the groups on gender, age, status as married/
cohabiting, educational level, having full-time ordinary work at baseline, lifetime affective or anxiety
disorders, number of mental disorders, number of SUDs or having only AUD at baseline (all p > 0.05).
Participants with current problematic substance use had more personality disorders at baseline (3.69
vs. 2.28, p = 0.013), scored higher onmental distressmeasured by the HSCL-25 at baseline (mean score
2.34 vs. 1.98, p = 0.006) and were younger at first onset of SUD (19.3 vs. 22.5 years, p = 0.035)
compared to those with no current problematic substance use. Although the subgroups were small,
we also compared the groups on specific lifetime mental disorders instead of clustered lifetime
affective or anxiety disorders (not shown in the table). Participants with current problematic substance
use more often had lifetime agoraphobia with or without panic disorder at baseline than participants
with no current problematic substance use (60% vs. 36%, p = 0.038), while there were no differences
between the groups for lifetime major depressive (50% vs. 54%, p = 0.729), specific phobia (47% vs.
40%, p = 0.501), social phobia (49% vs. 46%, p = 0.844), post-traumatic stress (14% vs. 23%, p = 0.308),
and somatization (25% vs. 29%, p = 0.702) disorder at baseline.
Table 3 shows the results from a logistic regression model (n = 75) using selected predictors,
based on results presented in Table 2, of having current problematic substance use at the time of
the 18-year follow-up study. HSCL-25 mean score at baseline was a significant predictor of having
current problematic substance use at the time of the 18-year follow-up study (OR = 3.24, 95% CI
1.08–9.68, p = 0.035), when adjusted for gender, age, number of personality disorders at baseline,
and age at onset first SUD.
4. Discussion
In a group of patients with long-term problematic substance use and high psychiatric comorbidity
that entered SUD treatment, close to half of those participating in a follow-up study had current
problematic substance use 18 years later. Only one-fifth reported total abstinence during the
5 years preceding the 18-year follow-up. Mental distress at baseline was a predictor of having
current problematic substance use at the time of the 18-year follow-up study, and also when
adjusted for other factors. Various demographic factors, lifetime mental disorders, personality
disorders, and substance use factors at baseline were not found to be predictors of having current
problematic substance use 18 years after treatment.
Despite the high extent of substance use, therewas a decrease over time. All participants had one or
several SUDs at baseline and only about half of the participants had current problematic substance use
at the 18-year follow-up. At the time of the 6-year follow-up study of this cohort (Landheim et al.,
2006), more than two thirds of the participants at the 18-year follow-up had current problematic
substance use, indicating a gradual decrease in problematic substance use over time. This finding is
consistent with a review on the long-term course of opioid addiction in clinical samples (Hser et al.,
2015), and a general decrease in problematic substance use over time found in several longitudinal
clinical dual-diagnosis studies (Drake et al., 2006; Xie, Drake, McHugo, Xie, & Mohandas, 2010) and
epidemiological studies (Heyman, 2013). In our cohort participants had high psychiatric comorbidity
with long duration and high severity of SUD, which are features often associated with poor outcomes
(Ciraulo et al., 2003; Morisano et al., 2014). Prognosis for the long-term course of SUD will probably be
better in cohorts with a shorter duration of SUD and lower psychiatric comorbidity.
Mental distress measured at baseline was found to be a predictor of having current problematic
substance use at the time of the 18-year follow-up study. Negative affective states are a known
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predictor of SUD relapse (Ciraulo et al., 2003), and our results are consistent with earlier findings
that psychological distress predicted substance use 10 years later in a clinical cohort with opioid
dependence (Hser, 2007). An association between mental distress measured by the HSCL-25 and
the long-term course of SUD has also been reported (Andreas et al., 2015). Our multivariate
analysis has substantial unexplained variance and several potential predictors (e.g. treatment
after baseline, genetic or biological variables) were not adjusted for. It is likely that mental distress
and SUDs have a bidirectional relationship over time, and have shared genetic predisposition
(Kendler, Prescott, Myers, & Neale, 2003).
Psychiatric diagnoses were not found to predict current problematic substance use at the 18-
year follow-up, which differs from findings in a review on relapse among individuals diagnosed
with co-occurring mental health and substance use disorders (Bradizza, Stasiewicz, & Paas,
2006). It also differs from the 6-year follow-up of the same cohort where lifetime major
depressive disorder at baseline was a predictor of having current problematic substance use
(Landheim et al., 2006). This could be an effect of differences between participants at the
6-year and 18-year follow-up studies because of loss of participants to death and nonparticipa-
tion, although statistical comparisons do not support this interpretation. Negative results on
diagnoses may be related to clustering single diagnoses into “affective” or anxiety “disorders”,
or sample size limitations on single diagnoses, but secondary bivariate or multivariate statistical
analysis do not support such effects. High baseline prevalence of both affective and anxiety
disorders in the cohort can make differences difficult to detect (cf. Berkson`s fallacy (Sackett,
1979)). At baseline psychiatric diagnosis was measured as lifetime instead of current diagnosis.
This does not likely explain the negative result for psychiatric diagnoses, because analyzing
diagnosis during the previous 12 months at baseline gave the same results as lifetime diag-
nosis. Negative findings for psychiatric diagnoses could also be related to differences between
results for structured diagnostic interviews, as we used, compared with diagnoses set by clinical
experts, who likely set fewer diagnoses (Andrews & Peters, 1998). Another interpretation could
be that measures from self-administered continuous symptom items yield better predictive
results for the long-term course of substance use than responses to dichotomous diagnostic
items in personal interviews. If these results are valid, one interpretation may be that predictors
of substance use relapse change over time. This seems to be the case when we compare results
for, for example, mental distress and lifetime major depressive disorders at baseline as pre-
dictors of having current problematic substance use at 6-year follow-up versus 18-year follow-
up. Psychiatric diagnoses with defined clusters of symptoms may be better short-term predic-
tors, while general mental health symptoms may be more relevant predictors of the long-term
course of SUDs. Studies that find mental disorders as predictors of substance use relapse
typically have shorter observation times than 18 years (Bradizza et al., 2006).
At the 6-year follow-up study on this cohort, early onset of SUD was a predictor of having current
problematic substance use (Landheim et al., 2006), but age at onset SUD was not found to be
a predictor in the 18-year follow-up study. This negative finding for early onset SUD can be an
effect of the cohort being skewed toward higher frequency of AUD and older patients at baseline
and loss of participants to death and nonparticipation in the 18-year follow-up study.
4.1. Limitations
Our cohort with long lasting SUDs and high psychiatric comorbidity at baseline, is clearly vulnerable to
selection bias (Sackett, 1979). A substantial decrease of participants because of mortality and
nonparticipation is inevitable in such a cohort, and may lead to attrition bias. As shown in Table 1,
there were differences in baseline characteristics as age, onset, duration and type of SUD, affective
disorders or type of treatment received at baseline between participants and deceased at the 18-year
follow-up that may have influenced the results. Although we found no differences in baseline
characteristics between participants and nonparticipants, there may be systematic differences
between the groups. Few participants and small subgroups, especially on specific psychiatric diag-
nosis, at the 18-year follow-up can possibly cause type-II statistical errors (Liebert & Liebert, 1995).
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Current substance use and mental distress may influence participation and the proportions of
participants with or without current problematic substance use at the 18-year follow-up study.
There can also be problems in measuring lifetime mental disorders at baseline in temporal proximity
to substance abuse. Especially the MCMI-II can generate false-positive personality disorder diagnoses
(Flynn, 1995) and lack stability (Samuel et al., 2011; Zimmerman, 1994). Also, it is not optimal that the
personality disorder diagnoses correspond to the DSM-III-R which is older and somewhat different to
the DSM-IV and ICD-10 which are used for the other diagnoses from CIDI in the study. All data at the
time of the 18-year follow-up study were self-reported and can be prone to recall bias (Coughlin,
1990) and skewed self-presentation (Mortel, 2008), which may lead to both under- or over reporting
of substance use depending of subjects` current state while filling out the questionnaire. There was
no monitoring of the self-reported data, so we do not know number of sessions or time used to
answer the questions, issues which may affect the quality of the data.
The main strengths of the study were the 18-year observation time, a heterogeneous clinical
cohort with long-term problematic substance use and a thorough diagnostic investigation with
structured personal interviews at baseline. Despite possible limitations, this study provides useful
unique data on the long-term course of SUDs and may help to direct future research.
4.2. Conclusions
In a group of patients with long lasting SUDs and high psychiatric comorbidity who entered SUD
treatment, close to half of those participating in a follow-up study had current problematic
substance use 18 years later. Mental distress at baseline was a predictor of having current
problematic substance use 18 years after treatment, adjusted for other factors. Self-reported
general mental health symptoms can be a relevant predictor of the long-term course of SUDs.
To prevent prolonged problematic substance use after SUD treatment, it is important to investigate
and treat mental health symptoms.
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